Microsoft word - current apsa2013 programme 25 nov

What do the threshold learning outcomes in pharmacy mean Introduction to questionnaire design and analysis James Green and Pauline Norris Hunter Centre Computer Lab Conference Opening / Mihi Whakatau (Hunter Centre Atrium, Cnr Frederick & Great King Streets) Mark Brunton, Research Manager Māori, University of Otago Peter Crampton, Pro-Vice-Chancellor, Health Sciences, Dunedin School of Medicine Rhiannon Braund, Conference Convenor APSA2013, School of Pharmacy, University of Otago Patients’ expectations of treatment: positive and negative influences on therapeutic outcome Keith Petrie, Auckland University Medical School, New Zealand Legend: Hunter Centre Atrium Barnett Colquhoun Hunter Centre Ground Floor Hunter Centre 1st Floor Bridging the adherence gap between efficacy and effectiveness Bernard Vrijens, University of Liège, Belgium CP01 – Drug Design and Formulation (Rm CP03 – Pharmacy Practice (Rm 122 & 123) Chitosan Coated Nanostructured Lipid Carriers Do animal patients have a place in a pharmacy How times change: The profession’s opinion of “One needs to adapt to others, not force others to Why do developed countries vary in medicines responsible for lymphatic transport of a adapt to your ways.” Exploring the perceptions of reclassification? A nine country qualitative pharmacy students following participation in a cross cultural simulation and introductory lecture Evaluation of drug absorption from lipid-based What is the relationship between pharmacy Attention pharmacists – disability support formulations using a coupled in vitro lipid students’ preferred teacher qualities and their Prevalence of, and attitudes towards, cognitive User testing of over-the-counter medicine labels dispersible CdTe/CdS quantum dots in rat liver: enhancer use amongst New Zealand tertiary and leaflets in Australia and UK: a comparative comparison with cationic and anionic dyes Inhalable powder formulation of combination Pharmacy students’ attitudes to, and use of, Indonesian pharmacists’ awareness of secondary antibiotics with high aerosol efficiency and prevention of cardiovascular disease: a study in Legend: Hunter Centre Atrium Barnett Colquhoun Hunter Centre Ground Floor Hunter Centre 1st Floor CP01 – Drug Design and Formulation (Rm 120 CP03 – Pharmacy Practice (Rm 122 & 123) Phytantriol cubosomes sterically stabilised with A question prompt list (QPL) for parents of accredited pharmacists providing directed Home children with attention-deficit hyperactivity formulation, characterisation and permeability Medicines Review following acute coronary disorder (ADHD): Part II- validation using Delphi studies in an in vitro model of the blood-brain Strategies for developing high dose powders for inhalation to treat The role of pharmacists in mental health: the challenges and The impact of disease on drug transport across the blood-brain Influencing health behaviours during pregnancy for the health of Fluorescent probes as drug discovery tools Developing, implementing and evaluating deprescribing guidelines for the elderly: A mixed methods approach Lalitha Raman-Wilms, University of Toronto Afternoon Tea/Poster Session 1 (Posters authors present for even numbers) Legend: Hunter Centre Atrium Barnett Colquhoun Hunter Centre Ground Floor Hunter Centre 1st Floor APSA Annual General Meeting – Room G30 Carrington College (off site – refer map) Legend: Hunter Centre Atrium Barnett Colquhoun Hunter Centre Ground Floor Hunter Centre 1st Floor Plenary 3 - NZCRS Session 1 – The biological therapeutic interface Good cop, bad cop: Intracellular trafficking and its implications for drug targeting Peter Swaan, University of Maryland, Baltimore, USA NZCRS Lecture – The biological therapeutic interface Written information as a tool to promote patient-centred care Preclinical formulation of therapeutics – what does industry want? Parisa Aslani, University of Sydney, Australia Thomas Rades, University of Copenhagen, Denmark NZCRS Session 1 - The biological therapeutic CP04 – Medication Safety (Rm 120 & 121) interface (Rm 122 & 123) * NZCR CP session times differ from CP04 & 05 Trends in Australian antipsychotic usage 1992- Would the separation of the clinical check and the Epithelial cell-targeting nanoparticles for oral mechanical process of dispensing have an impact delivery of protein drugs & the influence of mucus on public safety?- New Zealand pharmacists’ Utilisation of psychotropic medicines in older An evaluation of clinical services provided by pharmacists co-located in general practice clinics: Cell-penetrating peptides to enhance cell uptake the Pharmacists in Practice Study (PIPS) Do positive attitudes to pharmacists mean that pharmacies are the first port of call for minor Protein instability on interfaces – implications for dosage form design Legend: Hunter Centre Atrium Barnett Colquhoun Hunter Centre Ground Floor Hunter Centre 1st Floor NZCRS Session 1 - The biological therapeutic CP04 – Medication Safety (Rm 120 & 121) Medicine use among elderly Australians before Improving osteoporosis management in general Mastitis in dairy cattle – A challenge for the drug practice: a pharmacist-led drug use evaluation The relationship between organisational climate The use of compounded melatonin by children: and prescribing practices in Residential Aged Care Facilities (RACFs) from the perspective of Health Care Professionals (HCPs) NZCRS Session 2 – Progressing ideas to the Of mice and math: a link from the lab to opportunities in pharmaceutical research perceptions in hypertension - James Green Clinical oncology in companion animals – opportunities for translational research Jonathan Bray Afternoon Tea/Poster Session 2 (Poster authors present for odd numbers) Legend: Hunter Centre Atrium Barnett Colquhoun Hunter Centre Ground Floor Hunter Centre 1st Floor NZCRS Session 3 – Advances in delivery of cancer therapeutics (Rm 122 & 123) Turning weapons of mass destruction into precision guided munitions Nanomicelle based novel treatments for prostate cancer Nanomedicine combination of micellar crizotinib and dasatinib for the treatment of glioblastoma multiforme Hayley Nehoff – Bus departs Carrington College 6.20 pm, The Hunter Centre 6.30 pm, Scenic Hotel Southern Cross 6.40 pm Legend: Hunter Centre Atrium Barnett Colquhoun Hunter Centre Ground Floor Hunter Centre 1st Floor The future is now: the importance of medication review (Chapter 2) Gregory Peterson, University of Tasmania, Australia CP09 – Pharmacy Education (Rm 122 & 123) Cellular activity of antioxidant extracts from pūhā Drug-related problems in pain management in Learning and assessment connections between the internship and undergraduate years of Otago BPharm students – a longitudinal study Prevalence of factors that influence prescribing of An international validation study of two student dysfunction and activation of caspases in NRK-52E key therapies at discharge following acute Antifungal drug discovery – Crystallization of the Examining the appropriateness of prescribing in Developing a peer-led patient safety education older people in care homes in New Zealand using Unexpected in vitro cell uptake of norketotifen Tasmanian atrial fibrillation study: baseline Assessment of pharmacists’ knowledge and application of pharmacologic risk assessment tools in older adults using a continuing professional development educational method PEGylation increases the distribution and An evaluation of patients’ adherence with hypo- Evaluating the understanding of the process, and transfection efficiency of DNA vaccine lipoplexes use of, reflective thinking among undergraduate Guineans with type 2 diabetes: influencing Legend: Hunter Centre Atrium Barnett Colquhoun Hunter Centre Ground Floor Hunter Centre 1st Floor CP09 – Pharm Education (Rm 122 & 123) Linking solid state issues to the precipitation behaviour of poorly soluble drugs from lipid Legend: Hunter Centre Atrium Barnett Colquhoun Hunter Centre Ground Floor Hunter Centre 1st Floor

Source: http://www.events4you.co.nz/uploads/62715/files/Current_APSA2013_Programme_FINAL.pdf